Cargando…

The Gut Hormones PYY(3-36) and GLP-1(7-36 amide) Reduce Food Intake and Modulate Brain Activity in Appetite Centers in Humans

Obesity is a major public health issue worldwide. Understanding how the brain controls appetite offers promising inroads toward new therapies for obesity. Peptide YY (PYY) and glucagon-like peptide 1 (GLP-1) are coreleased postprandially and reduce appetite and inhibit food intake when administered...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Silva, Akila, Salem, Victoria, Long, Christopher J., Makwana, Aidan, Newbould, Rexford D., Rabiner, Eugenii A., Ghatei, Mohammad A., Bloom, Stephen R., Matthews, Paul M., Beaver, John D., Dhillo, Waljit S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2011
Materias:	Short Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267038/ https://www.ncbi.nlm.nih.gov/pubmed/22000927 http://dx.doi.org/10.1016/j.cmet.2011.09.010

Ejemplares similares

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity
por: De Silva, Akila, et al.
Publicado: (2012)

Combination of Peptide YY(3–36) with GLP-1(7–36 amide) Causes an Increase in First-Phase Insulin Secretion after IV Glucose
por: Tan, Tricia M., et al.
Publicado: (2014)

Imaging the neuroendocrinology of appetite
por: Salem, Victoria, et al.
Publicado: (2012)

The Use of Functional MRI to Study Appetite Control in the CNS
por: De Silva, Akila, et al.
Publicado: (2012)

PYY(3–36) and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
por: Field, Benjamin C.T., et al.
Publicado: (2010)

Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic
por: Sukkar, Samir Giuseppe, et al.
Publicado: (2013)

Effects of 2 Novel PYY(1-36) Analogues, (P(3)L(31)P(34))PYY(1-36) and PYY(1-36)(Lys(12)PAL), on Pancreatic Beta-Cell Function, Growth, and Survival
por: Lafferty, Ryan A, et al.
Publicado: (2019)

SAT-607 The Vagus Nerve and the Hypothalamus Mediate Different Aspects of the Anorectic Effects of PYY(3-36)
por: Alonso, Aldara Martin, et al.
Publicado: (2020)

GLP-1(28-36)amide, a Long Ignored Peptide Revisited
por: Zhou, Bilan, et al.
Publicado: (2014)

Serum lipase activity and concentration during intravenous infusions of GLP‐1 and PYY (3‐36) and after ad libitum meal ingestion in overweight men
por: Schmidt, Julie B., et al.
Publicado: (2016)

The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents
por: Psichas, A, et al.
Publicado: (2015)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

L‐Arginine Increases Postprandial Circulating GLP‐1 and PYY Levels in Humans
por: Amin, Anjali, et al.
Publicado: (2018)

No Evidence That Circulating GLP-1 or PYY Are Associated with Increased Satiety during Low Energy Diet-Induced Weight Loss: Modelling Biomarkers of Appetite
por: Lim, Jia Jiet, et al.
Publicado: (2023)

The Central Effects of Thyroid Hormones on Appetite
por: Amin, Anjali, et al.
Publicado: (2011)

GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
por: Taing, Meng-Wong, et al.
Publicado: (2014)

PYY Levels and Relationship to Appetite Across Different Presentations of Anorexia Nervosa
por: Muhammed, Maged, et al.
Publicado: (2021)

GLP-1 (7–36) amide restores myocardial insulin sensitivity and prevents the progression of heart failure in senescent beagles
por: Chen, Melissa, et al.
Publicado: (2014)

GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese Mice
por: Tomas, Eva, et al.
Publicado: (2015)

The effect of fatty diacid acylation of human PYY(3-36) on Y(2) receptor potency and half-life in minipigs
por: Østergaard, Søren, et al.
Publicado: (2021)

The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers
por: Tan, Tricia, et al.
Publicado: (2017)

Presence and dynamics of leptin, GLP-1, and PYY in human breast milk at early postpartum
por: Schueler, Jessica, et al.
Publicado: (2013)

meso-3,6-Dioxopiperazine-2,5-diacetamide
por: Li, Ping, et al.
Publicado: (2011)

Angiotensin II Type 1 Receptor-Dependent GLP-1 and PYY Secretion in Mice and Humans
por: Pais, Ramona, et al.
Publicado: (2016)

The Effect of Exercise Intensity on Total PYY and GLP-1 in Healthy Females: A Pilot Study
por: Hallworth, Jillian R., et al.
Publicado: (2017)

Self-Assembly of Lipopeptides Containing Short Peptide Fragments Derived from the Gastrointestinal Hormone PYY(3–36): From Micelles to Amyloid Fibrils
por: Hutchinson, Jessica A., et al.
Publicado: (2019)

Toward a Medical Gastric Bypass: Chronic Feeding Studies With Liraglutide + PYY(3-36) Combination Therapy in Diet-Induced Obese Rats
por: Dischinger, Ulrich, et al.
Publicado: (2021)

Cardioprotective effects of GLP‐1(28‐36a): A degraded metabolite or GLP‐1’s better half?
por: Liu, Yangyang, et al.
Publicado: (2020)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects
por: Sathananthan, Matheni, et al.
Publicado: (2013)

DPP4 Inhibition, NPY(1-36), PYY(1-36), SDF-1α, and a Hypertensive Genetic Background Conspire to Augment Cell Proliferation and Collagen Production: Effects That Are Abolished by Low Concentrations of 2-Methoxyestradiol
por: Jackson, Edwin K., et al.
Publicado: (2020)

Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety
por: Brooks, Lucy, et al.
Publicado: (2016)

Liraglutide + PYY(3-36) Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements
por: Metzner, Valentin, et al.
Publicado: (2022)

Thermal Imaging Is a Noninvasive Alternative to PET/CT for Measurement of Brown Adipose Tissue Activity in Humans
por: Law, James, et al.
Publicado: (2018)

Differential Effects of Laparoscopic Sleeve Gastrectomy and Laparoscopic Gastric Bypass on Appetite, Circulating Acyl-ghrelin, Peptide YY3-36 and Active GLP-1 Levels in Non-diabetic Humans
por: Yousseif, Ahmed, et al.
Publicado: (2013)

OR06-2 Kisspeptin Enhances Brain Processing of Olfactory and Visual Cues of Attraction in Men
por: Yang, Lisa, et al.
Publicado: (2019)

Acute effects of glucagon‐like peptide‐1, GLP‐1(9–36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
por: Bremholm, Lasse, et al.
Publicado: (2017)

Ingestion of coffee polyphenols increases postprandial release of the active glucagon-like peptide-1 (GLP-1(7–36)) amide in C57BL/6J mice
por: Fujii, Yoshie, et al.
Publicado: (2015)

A high carbohydrate, but not fat or protein meal attenuates postprandial ghrelin, PYY and GLP-1 responses in Chinese men
por: Parvaresh Rizi, Ehsan, et al.
Publicado: (2018)

Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome
por: Zhao, Zhikang, et al.
Publicado: (2020)

Effects of Neurokinin B Administration on Reproductive Hormone Secretion in Healthy Men and Women
por: Jayasena, Channa N., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u0q2j0ufdado0vc7mft3f1ospa